Search

Your search keyword '"Dalbies, Florence"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Dalbies, Florence" Remove constraint Author: "Dalbies, Florence"
28 results on '"Dalbies, Florence"'

Search Results

6. A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease

7. Natural history of untreated patients with type 1 Gaucher disease

8. French experience in the evaluation of plasma CCL18 levels in Gaucher Disease type 1

9. Untreated patients with type 1 Gaucher disease: who are they? Resultas from the Gaucher Non-Treated study (GANT study)

10. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy

12. The intra-monocyte pharmacokinetics of imiglucerase suggests a possible personalization of enzyme replacement therapy in patients with GD1

13. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

14. The French Gaucher Disease Registry: Clinical characteristics, complications and treatment of 616 patients

15. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.

16. Anti-CD20 antibody-mediated apoptosis of B cells is a lipid raft-dependent process in lupus and chronic lymphocytic leukemia

22. Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

23. Monoclonal Gammopathy (MG) Associated with Gaucher Disease (GD). Report of 16 Cases from the French Observatoire on Gaucher Disease (FROG Study).

26. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.

27. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy.

28. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).

Catalog

Books, media, physical & digital resources